South African tycoon Adrian Gore earns $1.7 million salary from Discovery in 2024
Discovery CEO and Co-founder Adrian Gore’s 2024 compensation package comprises a secure base pay of $448,843 and a performance-based short-term incentive of $565,687.
South African tycoon
Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
South African tycoon Terrence Moolman’s Caxton stake surges above $130 million
This surge is driven by the sustained rise in the shares of the leading publisher of books, newspapers, and magazines on the Johannesburg Stock Exchange (JSE).
South Africa’s Jonathan Jawno makes $4 million from Transaction Capital stake
Although the recent surge boosted investor confidence, Transaction Capital shares remain down 57.28 percent year-to-date.
Aspen’s market slump wipes $52 million from South African tycoon Gus Attridge’s stake
Attridge, who serves as the group’s chief advisor, holds a 4.3-percent stake in the Durban-based pharmaceutical giant, amounting to 19,033,829 shares.
South African tycoon Terrence Moolman sees $9.2-million increase from Caxton shares
This gain brings his total holdings to nearly $130 million, reinforcing his position as a leading figure in South Africa's media industry.
South African tycoon Stephen Brookes gains $2.3 million from Balwin stake in 10 days
Real estate mogul Stephen Brookes, the founder and the largest shareholder of Balwin Properties, owns 36.08 percent of the Johannesburg-based property developer.
South African tycoon Giovanni Ravazzotti’s Italtile stake nears $330 million
Ravazzotti’s stake in Italtile nears $330 million thanks to a $21.9-million gain in 14 days.
Aspen’s 20-percent stock decline costs South African tycoon Stephen Saad nearly $160 million
Saad's wealth drops by nearly $160 million after Aspen Pharmacare's shares tumble 20.17 percent over the past 25 days on the JSE.
South African tycoon Christopher Seabrooke's Sabvest Capital stake drops by $4.44 million
Christopher Seabrooke’s stake in Sabvest Capital dips below $70 million as shares slide.
